电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptide

DIRC2 宿主: 合成 BP, WB
产品编号 ABIN8098989
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptide (ABIN8098989)

抗原

DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))

资源

  • 2
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 蛋白结构域

    Middle Region

    原理

    DIRC2 Peptide - middle region
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    This is a synthetic peptide designed for use in combination with anti-DIRC2 antibody ( ARP50133_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    缓冲液

    Lyophilized powder

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • 抗原

    DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))

    背景

    Background Information: DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence and transcripts to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.

    Alternative Symbols: FLJ14784, RCC4

    分子量

    52kDa

    基因ID

    84925

    NCBI登录号

    NP_116228

    UniProt

    Q96SL1
You are here: